Ram Thapa

1.5k total citations
51 papers, 817 citations indexed

About

Ram Thapa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ram Thapa has authored 51 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Ram Thapa's work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Ram Thapa is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Ram Thapa collaborates with scholars based in United States, Nepal and Brazil. Ram Thapa's co-authors include Victoria Isaac, Leandro Castello, Dung‐Tsa Chen, Jhanelle E. Gray, Ben Creelan, Scott Antonia, Tawee Tanvetyanon, Eric B. Haura, Amer A. Beg and Theresa A. Boyle and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Statistical Association.

In The Last Decade

Ram Thapa

48 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ram Thapa United States 15 298 237 148 131 122 51 817
Kenji Murata Japan 14 334 1.1× 282 1.2× 225 1.5× 35 0.3× 74 0.6× 49 764
James P. O’Keefe United States 15 193 0.6× 270 1.1× 383 2.6× 182 1.4× 33 0.3× 25 962
P. De Angelis Norway 17 326 1.1× 439 1.9× 130 0.9× 119 0.9× 54 0.4× 37 1.3k
Karen Davidson United States 15 121 0.4× 344 1.5× 33 0.2× 88 0.7× 123 1.0× 26 700
Yutaka Kawakami Japan 19 140 0.5× 228 1.0× 122 0.8× 144 1.1× 18 0.1× 31 932
Alexandra Lainé France 16 205 0.7× 531 2.2× 321 2.2× 81 0.6× 121 1.0× 38 1.1k
Masato Sasaki Japan 17 104 0.3× 221 0.9× 62 0.4× 58 0.4× 255 2.1× 62 852
David L. Perkins United States 23 106 0.4× 206 0.9× 617 4.2× 367 2.8× 34 0.3× 31 1.2k
Jeremy J. Hammen United States 10 170 0.6× 205 0.9× 450 3.0× 202 1.5× 8 0.1× 20 894
Amanda J. Oliver United Kingdom 16 518 1.7× 256 1.1× 458 3.1× 59 0.5× 199 1.6× 33 1.1k

Countries citing papers authored by Ram Thapa

Since Specialization
Citations

This map shows the geographic impact of Ram Thapa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ram Thapa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ram Thapa more than expected).

Fields of papers citing papers by Ram Thapa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ram Thapa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ram Thapa. The network helps show where Ram Thapa may publish in the future.

Co-authorship network of co-authors of Ram Thapa

This figure shows the co-authorship network connecting the top 25 collaborators of Ram Thapa. A scholar is included among the top collaborators of Ram Thapa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ram Thapa. Ram Thapa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thapa, Ram, et al.. (2024). Removal of carbon dioxide with adsorption-desorption cycling of an activated carbon bed: Effects of bed geometry and cycle parameters. International Communications in Heat and Mass Transfer. 160. 108289–108289. 4 indexed citations
2.
Saltos, Andreas, Tawee Tanvetyanon, Ben Creelan, et al.. (2023). Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results.. Journal of Clinical Oncology. 41(16_suppl). 9125–9125. 2 indexed citations
3.
Thapa, Ram, Michael Shafique, Andreas Saltos, et al.. (2023). Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation. Journal of Thoracic Disease. 15(11). 6115–6125. 4 indexed citations
4.
Chen, Dung‐Tsa, Andreas Saltos, Trevor Rose, et al.. (2023). Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy. Cancers. 15(9). 2521–2521. 2 indexed citations
5.
Marin‐Acevedo, Julian A., Ram Thapa, Sonam Puri, J. Kevin Hicks, & Jhanelle E. Gray. (2023). Clinical outcomes with frontline immunotherapy (IO) in BRAF-mutant NSCLC.. Journal of Clinical Oncology. 41(16_suppl). e21089–e21089. 1 indexed citations
6.
Chiappori, Alberto, Ben Creelan, Tawee Tanvetyanon, et al.. (2022). Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 28(11). 2313–2320. 50 indexed citations
7.
Wilson, Christopher M., Ram Thapa, Jonathan V. Nguyen, et al.. (2022). Tumor immune cell clustering and its association with survival in African American women with ovarian cancer. PLoS Computational Biology. 18(3). e1009900–e1009900. 9 indexed citations
8.
Chen, Dung‐Tsa, Wenyaw Chan, Zachary Thompson, et al.. (2021). Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer. PLoS ONE. 16(7). e0252041–e0252041. 4 indexed citations
9.
Perez, Lia, Hugo F. Fernández, Mohamed A. Kharfan‐Dabaja, et al.. (2021). A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention. Blood Advances. 5(13). 2740–2750. 9 indexed citations
10.
Gray, Jhanelle E., Andreas Saltos, Tawee Tanvetyanon, et al.. (2019). Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer. Clinical Cancer Research. 25(22). 6623–6632. 104 indexed citations
11.
Emmons, Michael F., Fernanda Faião‐Flores, Ritin Sharma, et al.. (2019). HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy. Cancer Research. 79(11). 2947–2961. 52 indexed citations
12.
Kasting, Monica L., Claire C. Conley, Aasha I. Hoogland, et al.. (2019). A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors. Psycho-Oncology. 28(5). 980–988. 11 indexed citations
13.
Miura, John T., Lesly A. Dossett, Ram Thapa, et al.. (2019). Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes. Annals of Surgical Oncology. 27(1). 196–202. 5 indexed citations
14.
Reblin, Maija, Monica L. Kasting, Courtney L. Scherr, et al.. (2018). Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors. The Breast Journal. 25(1). 117–123. 6 indexed citations
15.
Luu, Carrie, Ram Thapa, Trevor Rose, et al.. (2018). Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm. International Journal of Surgery. 58. 46–49. 14 indexed citations
16.
Chiappori, Alberto, Charles C. Williams, Jhanelle E. Gray, et al.. (2018). Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer. Cancer Immunology Immunotherapy. 68(3). 517–527. 50 indexed citations
17.
Ström, T., Louis B. Harrison, Anna R. Giuliano, et al.. (2017). Tumour radiosensitivity is associated with immune activation in solid tumours. European Journal of Cancer. 84. 304–314. 40 indexed citations
18.
Luu, Carrie, Ram Thapa, Domenico Coppola, et al.. (2017). Does histology really influence gastric cancer prognosis?. Journal of Gastrointestinal Oncology. 8(6). 1026–1036. 14 indexed citations
19.
Brohl, Andrew S., Nikhil I. Khushalani, Zeynep Eroglu, et al.. (2016). A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma. Journal for ImmunoTherapy of Cancer. 4(1). 85–85. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Murata Breakdown of academic impact, for papers by James P. O’Keefe Breakdown of academic impact, for papers by P. De Angelis Breakdown of academic impact, for papers by Karen Davidson Breakdown of academic impact, for papers by Yutaka Kawakami Breakdown of academic impact, for papers by Alexandra Lainé Breakdown of academic impact, for papers by Masato Sasaki Breakdown of academic impact, for papers by David L. Perkins Breakdown of academic impact, for papers by Jeremy J. Hammen Breakdown of academic impact, for papers by Amanda J. Oliver
Rankless by CCL
2026